Azienda Ospedaliera Citta della Salute e della Scienza di Torino

Turin, Piedmont 10126

0 studies enrolling now · 4 studies all time

What they study most

Acute Myeloid Leukemia (AML), Autologous Stem Cell Transplant, Lymphoma, Non-Hodgkin, Multiple Myeloma, Relapsed and/or Refractory Multiple Myeloma

Studies at this site

• A Study of Pevonedistat and Venetoclax Combined With Azacitidine to Treat Acute Myeloid Leukemia (AML) in Adults Unable to Receive Intensive Chemotherapy — Completed
• A Study of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Participants With Multiple Myeloma Following Autologous Stem Cell Transplant — Completed
• A Study of TAK-981 Given With Rituximab in Adults With Relapsed or Refractory CD20-Positive Non-Hodgkin Lymphoma — Stopped early
• A Study of Ixazomib, Given With Dexamethasone in Adults With Multiple Myeloma — Completed